AM Rx review

What it is

AM Rx is a telehealth service operated by AM Rx, LLC, which lists an address in Dover, Delaware. The FDA addressed its warning letter to FitRX, LLC, doing business as AM RX, at 30 Irving Place in New York, the same company that runs the Zealthy and FitRx brands. Medical care comes from Bruno Health, P.A. and affiliated medical groups, with U.S.-licensed, board-certified physicians and nurse practitioners; AM Rx provides management and administrative services to them. Besides weight loss, it offers primary care, mental health care, birth control, hair loss, skin care, erectile dysfunction and enclomiphene. It says services are available in all 50 states, with some variation by state. Disputes go to binding individual arbitration. The site doesn't display a LegitScript seal.

How it works

You create an account and answer health questions online, which it says takes about five minutes, and a provider reviews your answers within one to two business days to build a plan that may include a GLP-1. Same-day appointments are available for other care. After that, the membership gives you unlimited secure messaging with your provider, monthly video or phone visits, a care coordinator in the portal and a dedicated coach for nutrition and fitness. If a brand-name GLP-1 is prescribed, the insurance coordination team handles the prior authorization and can submit up to three requests. While you wait, or if coverage is denied, many members start on compounded semaglutide or tirzepatide, which ships from a partner pharmacy and usually arrives within five to nine business days of approval. Three-month orders typically arrive in one package.

Pricing transparency

The membership is $39 for the first month and $135 a month after that, billed monthly on the same date, and it doesn't include medication. Compounded semaglutide starts at $106 a month and compounded tirzepatide at $216 a month when bought as a three-month supply, with shipping included; one-month supplies are offered, but their price isn't published. Some members get 20% off the membership for two months with a three-month order. Bundled plans with compounded medication included are listed at $217 for the first month for semaglutide and $349 for tirzepatide, without the ongoing price. With insurance, brand-name drugs can cost as little as a $25 copay, and you keep paying the membership. You can cancel any time under Manage Membership, and access continues to the end of the paid period, but membership, consultation and visit fees aren't refunded or prorated, and medication sales are final. If you're found ineligible for compounded medication, there's a 30-day satisfaction guarantee with a refund.

Branded vs compounded

Providers prescribe brand-name Wegovy, Zepbound, Ozempic and Mounjaro, usually through insurance, and compounded semaglutide and tirzepatide by weekly injection. Wegovy and Zepbound are FDA-approved for weight management; Ozempic and Mounjaro are approved for type 2 diabetes. Compounded versions are not FDA-approved. In June 2026 the FDA sent FitRX, LLC, doing business as AM RX, a warning letter about this website. The agency said product images labeled "AM Rx" suggested the company was the compounder when it is not, and that calling its compounded semaglutide the active ingredient in Ozempic and Wegovy implied FDA approval. The weight page today uses that same description, so read it as describing the molecule, not the product you'd receive. The same company received letters in September 2025 for Zealthy and February 2026 for FitRx. The AM Rx letter is disclosed and linked on this page.

Pros and watch-outs

The evidence behind what AM Rx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How AM Rx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Found

  Compounded GLP-1 with the drug included, and insurance for the visits

  See Found →
• yourEra

  A low-cost entry point into compounded GLP-1 treatment

  See yourEra →
• Zealthy

  People with insurance who want help getting a brand-name GLP-1 covered, with a compounded fallback while they wait

  See Zealthy →

More GLP-1 telehealth reviews: Alinwell · Andrew Meds · Bayan Health · Believe Health · Clume Health · Goldspan Health